Spire Healthcare Group (LON:SPI) Trading 14.5% Higher - Still a Buy?

Key Points

• Spires Healthcare Group's stock price surged by 14.5% to GBX 248 ($3.36) following a significant increase in trading volume, with over 37 million shares exchanged, marking a rise of 2,206% from the average volume.
• Wall Street analysts maintain a consensus rating of "Buy" on Spire Healthcare, with a revised average price target of GBX 294.33, despite JPMorgan reducing their price objective to GBX 303.
• The company's recent quarterly earnings revealed an EPS of GBX 4.10, while analysts project future earnings per share to be approximately 15.66 for the current fiscal year.

Spire Healthcare Group plc (LON:SPI - Get Free Report) shares traded up 14.5% during trading on Friday . The company traded as high as GBX 249 ($3.35) and last traded at GBX 248 ($3.34). 37,369,863 shares traded hands during trading, an increase of 2,206% from the average session volume of 1,620,847 shares. The stock had previously closed at GBX 216.50 ($2.92).

Analysts Set New Price Targets

Several brokerages have recently issued reports on SPI. Berenberg Bank reissued a "buy" rating and issued a GBX 280 price objective on shares of Spire Healthcare Group in a report on Thursday, July 31st. JPMorgan Chase & Co. decreased their price target on Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating on the stock in a research note on Tuesday, August 5th. Three research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company currently has an average rating of "Buy" and an average target price of GBX 294.33.

Spire Healthcare Group Price Performance

The company has a debt-to-equity ratio of 62.25, a quick ratio of 0.74 and a current ratio of 0.70. The firm has a market cap of £993.86 million, a price-to-earnings ratio of 5,369.57, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96. The company's fifty day moving average is GBX 218.75 and its two-hundred day moving average is GBX 203.41.

Spire Healthcare Group (LON:SPI - Get Free Report) last released its earnings results on Thursday, July 31st. The company reported GBX 4.10 earnings per share for the quarter. Spire Healthcare Group had a net margin of 1.96% and a return on equity of 3.82%. Equities research analysts forecast that Spire Healthcare Group plc will post 15.6634747 EPS for the current year.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.